Diamminetetrakis(carboxylato)platinum(IV) complexes - Synthesis, characterization, and cytotoxicity

Chemistry and Biodiversity

Volumn 9, Issue 9, 2012, Pages 1840-1848

  Hoffmeister, Björn R ^a   Adib Razavi, Mahsa S ^a   Jakupec, Michael A ^a   Galanski, Markus ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antiproliferative activity; Diamminetetrakis(carboxylato) complexes; Platinum complexes

Indexed keywords

CISPLATIN; DIAMMINE(MALONATO)BIS[(4 METHOXY) 4 OXOBUTANOATO]PLATINUM; DIAMMINE(MALONATO)BIS[(4 PROPYLAMINO) 4 OXOBUTANOATO]PLATINUM; DIAMMINE(MALONATO)BIS[(4 PROPYLOXY) 4 OXOBUTANOATO]PLATINUM; DIAMMINE(MALONATO)BIS[[4 (2 METHOXYETHOXY)] 4 OXOBUTANOATO]PLATINUM; DIAMMINE(MALONATO)BIS[[4 (PROP 2 YLOXY)] 4 OXOBUTANOATO]PLATINUM; DIAMMINEBIS(3 CARBOXYPROPANOATO)MALONATOPLATINUM; DIAMMINEBIS[(4 BUTYLOXY) 4 OXOBUTANOATO](MALONATO)PLATINUM; DIAMMINEBIS[(4 CYCLOPENTYLAMINO) 4 OXOBUTANOATO]MALONATOPLATINUM; DIAMMINEBIS[(4 ETHOXY) 4 OXOBUTANOATO](MALONATO)PLATINUM; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CARBON NUCLEAR MAGNETIC RESONANCE; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIPOPHILICITY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY CARCINOMA; PLATINUM NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 84866348488     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.201200019     Document Type: Article

References (35)

1. 'Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug', Ed. B. Lippert, Verlag Helvetica Chimica Acta, Zürich, Switzerland, 1999.
2. P. J. O'Dwyer, J. P. Stevenson, S. W. Johnson, Drugs 2000, 59, 19.
3. M. Galanski, M. A. Jakupec, B. K. Keppler, in 'Metal Compounds in Cancer Chemotherapy', Eds. J. M. Pérez, M. A. Fuertes, C. Alonso, Research Signpost, Kerala, 2005, pp. 155-185.
4. M. A. Jakupec, M. Galanski, B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1.
5. M. Galanski, M. A. Jakupec, B. K. Keppler, Curr. Med. Chem. 2005, 12, 2075.
6. M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger, B. K. Keppler, Dalton Trans. 2008, 183.
7. M. Galanski, B. K. Keppler, Anti-Cancer Agents Med. Chem. 2007, 7, 55.
8. M. D. Hall, T. W. Hambley, Coord. Chem. Rev. 2002, 232, 49.
9. M. Galanski, Recent Pat. Anti-Cancer Drug Discovery 2006, 1, 285.
10. M. Galanski, B. K. Keppler, Inorg. Chim. Acta 2000, 300-302, 783.
11. M. D. Hall, H. R. Mellor, R. Callaghan, T. W. Hambley, J. Med. Chem. 2007, 50, 3403.
12. C. M. Giandomenico, M. J. Abrams, B. A. Murrer, J. F. Vollano, M. I. Rheinheimer, S. B. Wyer, G. E. Bossard, J. D. Higgins, Inorg. Chem. 1995, 34, 1015.
13. M. Galanski, B. K. Keppler, Inorg. Chem. 1996, 35, 1709.
14. M. Galanski, B. K. Keppler, Inorg. Chim. Acta 1997, 265, 271.
15. J. J. Wilson, S. J. Lippard, Inorg. Chem. 2011, 50, 3103.
16. M. Galanski, W. Zimmermann, M. Berger, C. Baumgartner, G. Giester, B. K. Keppler, Eur. J. Inorg. Chem. 2002, 417.
17. M. Reithofer, M. Galanski, A. Roller, B. K. Keppler, Eur. J. Inorg. Chem. 2006, 2612.
18. V. Pichler, S. M. Valiahdi, M. A. Jakupec, V. B. Arion, M. Galanski, B. K. Keppler, Dalton Trans. 2011, 40, 8187.
19. W. H. Ang, I. Khalaila, C. S. Allardyce, L. Juillerat-Jeanneret, P. J. Dyson, J. Am. Chem. Soc. 2005, 127, 1382.
20. M. R. Reithofer, S. M. Valiahdi, M. Galanski, M. A. Jakupec, V. B. Arion, B. K. Keppler, Chem. Biodiversity 2008, 5, 2160.
21. S. Dhar, S. J. Lippard, Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 22199.
22. K. R. Barnes, A. Kutikov, S. J. Lippard, Chem. Biol. 2004, 11, 557.
23. S. Mukhopadhyay, C. M. Barnés, A. Haskel, S. M. Short, K. R. Barnes, S. J. Lippard, Bioconjugate Chem. 2008, 19, 39.
24. S. Abramkin, S. M. Valiahdi, M. A. Jakupec, M. Galanski, N. Metzler-Nolte, B. K. Keppler, Dalton Trans. 2012, 41, 3001.
25. R. P. Feazell, N. Nakayama-Ratchford, H. Dai, S. J. Lippard, J. Am. Chem. Soc. 2007, 129, 8438.
26. S. Dhar, Z. Liu, J. Thomale, H. Dai, S. J. Lippard, J. Am. Chem. Soc. 2008, 130, 11467.
27. S. Dhar, F. X. Gu, R. Langer, O. C. Farokhzad, S. J. Lippard, Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 17356.
28. S. Dhar, W. L. Daniel, D. A. Giljohann, C. A. Mirkin, S. J. Lippard, J. Am. Chem. Soc. 2009, 131, 14652.
29. M. R. Reithofer, S. M. Valiahdi, M. A. Jakupec, V. B. Arion, A. Egger, M. Galanski, B. K. Keppler, J. Med. Chem. 2007, 50, 6692.
30. M. R. Reithofer, A. Schwarzinger, S. M. Valiahdi, M. Galanski, M. A. Jakupec, B. K. Keppler, J. Inorg. Biochem. 2008, 102, 2072.
31. A. K. Bytzek, M. R. Reithofer, M. Galanski, M. Groessl, B. K. Keppler, C. G. Hartinger, Electrophoresis 2010, 31, 1144.
32. M. R. Reithofer, A. K. Bytzek, S. M. Valiahdi, C. R. Kowol, M. Groessl, C. G. Hartinger, M. A. Jakupec, M. Galanski, B. K. Keppler, J. Inorg. Biochem. 2011, 105, 46.
33. H. Varbanov, S. M. Valiahdi, A. A. Legin, M. A. Jakupec, A. Roller, M. Galanski, B. K. Keppler, Eur. J. Med. Chem. 2011, 46, 5456.
34. J. Z. Zhang, E. Wexselblatt, T. W. Hambley, D. Gibson, Chem. Commun. 2012, 48, 847.
35. S. C. Dhara, Indian J. Chem. 1970, 8, 193.